DE4419783A1 - Medicated shampoo for hair care and treatment - Google Patents

Medicated shampoo for hair care and treatment

Info

Publication number
DE4419783A1
DE4419783A1 DE4419783A DE4419783A DE4419783A1 DE 4419783 A1 DE4419783 A1 DE 4419783A1 DE 4419783 A DE4419783 A DE 4419783A DE 4419783 A DE4419783 A DE 4419783A DE 4419783 A1 DE4419783 A1 DE 4419783A1
Authority
DE
Germany
Prior art keywords
acid
extract
hair
ascorbate
texapon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE4419783A
Other languages
German (de)
Inventor
Carl Heinrich Dr Weischer
Heinz Dr Ulrich
Heward Dr Schindler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Priority to DE4419783A priority Critical patent/DE4419783A1/en
Publication of DE4419783A1 publication Critical patent/DE4419783A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A shampoo (I) for treatment and care of hair contains at least the following active agents: (A) oxidised or reduced enantiomers of alpha -lipoic acid, dihydrolipoic acid (racemate) or their esters, 6,8-bis-nor-lipoic acid, tetra-nor-lipoic acid, or 1,2-dithiacyclopentane-3-butylsulphonic acid or their alkali metal salts, at a concn. of 0.2-10%; and (B) one or more combination partners such as selenium salts, disodium salts, potassium salts of a condensation product of lauric acid and protein hydrolysate, palm-kernel fatty acid sarcoside of methyltaurine, palm kernel oil fatty acid sarcoside of triethanolamine, sodium salt of a condensation product of undecylenic acid, water-soluble vitamin E or F, ascorbic acid, beer extract, camomile flower extract or dye concentrates.

Description

Die vorliegende Erfindung betrifft ein Haarkur-Pflege-Shampoo, das sich insbesondere zur Behandlung von Haarausfall, Haarwuchsstörungen, zytostatika induzierte Alopezie, Haarbrüchigkeit, Kopfschuppen bei trockener und öliger Seborrhoe, impetignisierter Ekzeme und Pyodermien der Kopfhaut, seborrhoisches Ekzem des Haarbodens, seborrhisches Begleitsymptome der androgenetischen Alopezie und zur Verlängerung der Lebensdauer der Haare eignet.The present invention relates to a hair care shampoo, which is particularly for the treatment of hair loss, hair growth disorders, cytostatic-induced alopecia, Hair brittleness, dandruff on dry and oily seborrhea, impetignized Eczema and pyoderma of the scalp, seborrheic eczema of the hair floor, accompanying seborrhic symptoms of androgenetic alopecia and for prolongation the life of the hair.

Als Krankeitsbild wird beispielsweise Haarausfall, Haarwuchsstörungen, Seborrhoe, Kopfschuppen oder eine chronische Haarbodenentzündung, Haarbalgentzündung oder eine entzündliche ekzematöse Kopfhautveränderung beobachtet.The clinical picture is, for example, hair loss, hair growth disorders, seborrhea, Dandruff or a chronic inflammation of the hair follicles, hair follicles or an inflammatory eczematous scalp change was observed.

Die Aufgabe der vorliegenden Erfindung ist es, hier Abhilfe zu schaffen und ein Haarkur-Pflege-Schampoo mit synergistischer Wirkung durch Kombination von Wirkstoffen zur Verfügung zu stellen.The object of the present invention is to remedy this and a Hair treatment care shampoo with synergistic effect by combining To provide active ingredients.

Erfindungsgemäß wird das dadurch erreicht, daß man ein Haarkur-Pflege-Shampoo, bestehend aus mindestens den Wirkstoffen:According to the invention this is achieved by using a hair care shampoo, consisting of at least the active ingredients:

  • a) oxidierte oder reduzierte Enantiomere der α-Liponsäure, Dihydroliponsäure (Racemat) oder deren Ester, 6,8-Bisnorliponsäure, Tetranorliponsäure oder die 1,2- Dithiacyclopentan-3-butylsulfonsäure oder ihre Alkalisalze in einer Konzentration von beispielsweise 0,2 bis 10%, vorzugsweise 0,5 bis 4% unda) Oxidized or reduced enantiomers of α-lipoic acid, dihydrolipoic acid (Racemate) or its esters, 6,8-bisnorliponic acid, tetranorliponic acid or the 1,2- Dithiacyclopentan-3-butylsulfonic acid or its alkali salts in a concentration of for example 0.2 to 10%, preferably 0.5 to 4% and
  • b) ein oder mehrere Kombinationspartner, wie Selensalzen, Dinatriumsalz, Kaliumsalz eines Kondensationsproduktes aus Laurinsäure und Eiweißhydrolysaten, Palmkernfettsäure-Sarkosid des Methyltaurins, Palmölkernfettsäure-Sarkosid des Triethanolamins, Natriumsalz eines Kondensationsproduktes aus Undecylensäure, wasserlöslichen Vitamin E oder F, Ascorbinsäure, Bierextrakt, Kamillenblütenextrakt oder Farbkonzentraten einsetzt.b) one or more combination partners, such as selenium salts, disodium salt, potassium salt a condensation product of lauric acid and protein hydrolyzates, Palm kernel fatty acid sarcoside of methyl taurine, palm kernel fatty acid sarcoside of Triethanolamine, sodium salt of a condensation product from undecylenic acid, water soluble vitamin E or F, ascorbic acid, beer extract, chamomile flower extract or color concentrates.

Das Haarkur-Pflegeschampoo kann beispielsweise bestehen aus:The hair care shampoo can consist of:

  • a) oxidierten oder reduzierten Enantiomeren der α-Liponsäure, Dihydroliponsäure (Racemat) oder deren Ester, 6,8-Bisnorliponsäure, Tetranorliponsäure oder die 1,2- Dithiacyclopentan-3-butylsulfonsäure oder ihren Alkalisalze in einer Konzentration von beispielsweise 0,2 bis 8%, vorzugsweise 0,5 bis 4% und a) Oxidized or reduced enantiomers of α-lipoic acid, dihydrolipoic acid (Racemate) or its esters, 6,8-bisnorliponic acid, tetranorliponic acid or the 1,2- Dithiacyclopentan-3-butylsulfonic acid or its alkali salts in a concentration of for example 0.2 to 8%, preferably 0.5 to 4% and  
  • b) Natrium-Selenit, wasserlöslichen Vitamin E oder F, KM BRONIDOX L®, Kamillenblütenextrakt, TEXAPON EVR®, TEXAPON N25®, TEXAPON MLS®, TEXAPON N40®, TEXAPON N70®, TEXAPON MG®, EUPERLAN PK 776®, EUPERLAN PK 771®, COMPERLAN KD®, COMPERLAN 100®, COMPERLAN LS®, DEHYTON K®, Kokosfettsäure-diethanolamid, Fettalkoholethersulfat, Na-Laurylethersulfat, NUTRILAN I®, LAMERCIN 50-80®, Natriumchlorid, Konservierungsmittel, Parfümöl, Bierextrakt oder Farbkonzentraten.b) sodium selenite, water-soluble vitamin E or F, KM BRONIDOX L®, Chamomile flower extract, TEXAPON EVR®, TEXAPON N25®, TEXAPON MLS®, TEXAPON N40®, TEXAPON N70®, TEXAPON MG®, EUPERLAN PK 776®, EUPERLAN PK 771®, COMPERLAN KD®, COMPERLAN 100®, COMPERLAN LS®, DEHYTON K®, coconut fatty acid diethanolamide, fatty alcohol ether sulfate, Na lauryl ether sulfate, NUTRILAN I®, LAMERCIN 50-80®, sodium chloride, Preservatives, perfume oil, beer extract or color concentrates.

Die α-Liponsäure ist chemisch gesehen 1,2-Dithia-cyclopentan-3-valerieansäure und ist in Form des R-Enantiomers in Pflanzen und Tieren weit verbreitet. Sie wirkt in vielen enzymatischen Reaktionen als Coenzym, stellt einen Wachstumsfaktor für manche Bakterien und Protozoen dar und wird bei der Behandlung von Knollenblätterpilzvergiftungen eingesetzt.The α-lipoic acid is chemically 1,2-dithia-cyclopentan-3-valerieneansäure and is widely used in plants and animals in the form of the R enantiomer. It acts as a coenzyme in many enzymatic reactions Growth factor for some bacteria and protozoa and is in the Treatment of tuberous poisoning used.

Weiterhin weist das α-Liponsäure-Racemat antiphlogistische, antinociceptive (analgetische) sowie zytoprotektive, neuroprotektive, antiallergische und antitumor Eigenschaften auf.Furthermore, the α-lipoic acid racemate has anti-inflammatory, antinociceptive (analgesic) as well as cytoprotective, neuroprotective, anti-allergic and anti-tumor Properties on.

Die reinen, optischen Enantiomeren der α-Liponsäure (R- und S-Form, das heißt R-α- Liponsäure und S-α-Liponsäure) sind im Gegensatz zu dem Racemat wirksamer. Das R-Enantiomer ist vorwiegend antiphlogistisch und das S-Enantiomer antinociceptiv wirksam, wobei die antiphlogistische Wirkung des R-Enantiomer beispielsweise um einen Faktor 10 stärker ist als diejenige des Racemats.The pure, optical enantiomers of α-lipoic acid (R and S forms, i.e. R-α- In contrast to the racemate, lipoic acid and S-α-lipoic acid) are more effective. The R enantiomer is predominantly anti-inflammatory and the S enantiomer antinociceptive effective, the anti-inflammatory effect of the R enantiomer for example is a factor 10 stronger than that of the racemate.

Die antinociceptive (analgetische) Wirkung des S-Enantiomer ist beispielsweise um bis 6 Faktoren stärker als diejenigen des Racemats.The antinociceptive (analgesic) effect of the S enantiomer is, for example, up to 6 factors stronger than those of the racemate.

Die Enantiomeren der α-Liponsäure stellen daher im Vergleich zu dem Racemat sehr viel spezifischere und stärkerer wirksame Wirkstoffe dar.The enantiomers of α-lipoic acid are therefore very high compared to the racemate much more specific and powerful active ingredients.

Diese Wirkungen sind in EP-A 901 213 405 beschrieben.These effects are described in EP-A 901 213 405.

Dieser Synergismus wird vermutet durch den Schutz des Elastins, einem Bestandteil des Bindegewebes der Kopfhaut, durch die erfindungsgemäße Kombination mit der α-Liponsäure. Durch die beschriebene bekannte antiphlogistische und Kalziumfängereigenschaften der α-Liponsäure kommt es zur Hemmung der katabolen Enzyme. This synergism is suspected by the protection of elastin, a component of the connective tissue of the scalp, by the combination according to the invention with the α-lipoic acid. Through the well-known anti-inflammatory and Calcium scavenger properties of α-lipoic acid inhibit the catabolic Enzymes.  

Das Haarkur-Pflege-Schamoo kann beispielsweise in Tuben, Flaschen oder verschweißten Kunststoffbeuteln zur äußerlichen Anwendung vorliegen.The hair treatment care shamoo can, for example, be in tubes, bottles or welded plastic bags for external use.

AusführungsbeispieleEmbodiments Beispiel 1example 1

100 g Lösung enthält:100 g solution contains:

Beispiel 2Example 2

100 g Lösung enthält:100 g solution contains:

Beispiel 3Example 3

100 g Lösung enthält:100 g solution contains:

Beispiel 4Example 4

100 g Lösung enthält:100 g solution contains:

Beispiel 5Example 5

100 g Lösung enthält:100 g solution contains:

Beispiel 6Example 6

100 g Lösung enthält:100 g solution contains:

Beispiel 7Example 7

100 g Lösung enthält:.100 g of solution contains:

Claims (4)

1. Haarkur-Pflege-Shampoo bestehend aus mindestens den Wirkstoffen:
  • a) oxidierte oder reduzierte Enantiomere der α-Liponsäure, Dihydroliponsäure (Racemat) oder deren Ester, 6,8-Bisnorliponsäure, Tetranorliponsäure oder die 1,2- Dithiacyclopentan-3-butylsulfonsäure oder ihre Alkalisalze in einer Konzentration von 0,2 bis 10% und
  • b) einem oder mehreren Kombinationspartnern wie Selensalzen, Dinatriumsalz, Kaliumsalz eines Kondensationsproduktes aus Laurinsäure und Eiweißhydrolysaten, Palmkernfettsäure-Sarkosid des Methyltaurins, Palmölkernfettsäure-Sarkosid des Triethanolamins, Natriumsalz eines Kondensationsproduktes aus Undecylensäure, wasserlöslichen Vitamin E oder F, Ascorbinsäure, Bierextrakt, Kamillenblütenextrakt oder Farbkonzentraten.
1. Hair care shampoo consisting of at least the active ingredients:
  • a) oxidized or reduced enantiomers of α-lipoic acid, dihydroliponic acid (racemate) or their esters, 6,8-bisnorliponic acid, tetranorliponic acid or 1,2-dithiacyclopentane-3-butylsulfonic acid or its alkali salts in a concentration of 0.2 to 10% and
  • b) one or more combination partners, such as selenium salts, disodium salt, potassium salt of a condensation product from lauric acid and protein hydrolyzates, palm kernel fatty acid sarcoside of methyl taurine, palm oil kernel fatty acid sarcoside of triethanolamine, sodium salt of a condensation product from undecylenic acid, water-soluble vitamin E or F, bleach extract, ascorbate extract, ascorbate extract, ascorbate extract, ascorbate extract, ascorbate extract, ascorbate extract, ascorbate extract .
2. Haarkur-Pflege-Shampoo nach Anspruch 1 dadurch gekennzeichnet, daß es mindestens aus
  • a) oxidierten oder reduzierten Enantiomeren der α-Liponsäure, Dihydroliponsäure (Racemat) oder deren Ester, 6,8-Bisnorliponsäure, Tetranorliponsäure oder die 1,2- Dithiacyclopentan-3-butylsulfonsäure oder ihren Alkalisalze in einer Konzentration von 0,2 bis 8% und
  • b) einem oder mehreren Kombinationspartnern wie Natrium-Selenit, wasserlöslichen Vitamin E oder F, KM BRONIDOX L®, Kamillenblütenextrakt, TEXAPON EVR®, TEXAPON N25®, TEXAPON MLS®, TEXAPON N40®, TEXAPON N70®, TEXAPON MGOR, EUPERLAN PK 776®, EUPERLAN PK 771®, GOMPERLAN KD®, COMPERLAN 100®, COMPERLAN LS®, DEHYTON K®, Kokosfettsäure­ diethanolamid, Fettalkoholethersulfat, Na-Laurylethersulfat, NUTRILAN I®, LAMERCIN 50-80®, Natriumchlorid, Konservierungsmittel, Parfümöl, Bierextrakt oder Farbkonzentraten besteht.
2. Hair care shampoo according to claim 1, characterized in that it is at least
  • a) oxidized or reduced enantiomers of α-lipoic acid, dihydroliponic acid (racemate) or their esters, 6,8-bisnorliponic acid, tetranorliponic acid or 1,2-dithiacyclopentane-3-butylsulfonic acid or its alkali salts in a concentration of 0.2 to 8% and
  • b) one or more combination partners such as sodium selenite, water-soluble vitamin E or F, KM BRONIDOX L®, chamomile flower extract, TEXAPON EVR®, TEXAPON N25®, TEXAPON MLS®, TEXAPON N40®, TEXAPON N70®, TEXAPON MGOR, EUPERLAN PK 776 ®, EUPERLAN PK 771®, GOMPERLAN KD®, COMPERLAN 100®, COMPERLAN LS®, DEHYTON K®, coconut fatty acid diethanolamide, fatty alcohol ether sulfate, Na lauryl ether sulfate, NUTRILAN I®, LAMERCIN 50-80®, sodium chloride, preservative, perfume oil or beer extract Color concentrates exist.
3. Haarkur-Pflege-Shampoo nach Anspruch 1 dadurch gekennzeichnet, daß es insbesondere zur Behandlung von Haarausfall, Haarwuchsstörungen, Zytostatika induzierte Alopezie, Haarbrüchigkeit, Kopfschuppen bei trockener und öliger Seborrhoe, impetignisierter Ekzeme und Pyodermien der Kopfhaut, seborrhoisches Ekzem des Haarbodens, seborrhoisches Begleitsymptome der androgenetischen Alopezie und zur Verlängerung der Lebensdauer der Haare verwendet wird.3. hair care shampoo according to claim 1, characterized in that it especially for the treatment of hair loss, hair growth disorders, cytostatics induced alopecia, brittleness, dandruff in dry and oily Seborrhea, impetignized eczema and pyoderma of the scalp, seborrheic Eczema of the floor of the hair, accompanying seborrheic symptoms of androgenetic Alopecia and used to extend the life of the hair. 4. Haarkur-Pflege-Shampoo nach Anspruch 1 dadurch gekennzeichnet, daß die Wirkstoffe in Tuben, Flaschen oder verschweißten Kunststoffbeuteln zur äußerlichen Anwendung vorliegen.4. hair treatment shampoo according to claim 1, characterized in that the Active substances in tubes, bottles or welded plastic bags for external use Application.
DE4419783A 1994-06-06 1994-06-06 Medicated shampoo for hair care and treatment Withdrawn DE4419783A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE4419783A DE4419783A1 (en) 1994-06-06 1994-06-06 Medicated shampoo for hair care and treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4419783A DE4419783A1 (en) 1994-06-06 1994-06-06 Medicated shampoo for hair care and treatment

Publications (1)

Publication Number Publication Date
DE4419783A1 true DE4419783A1 (en) 1995-12-07

Family

ID=6519935

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4419783A Withdrawn DE4419783A1 (en) 1994-06-06 1994-06-06 Medicated shampoo for hair care and treatment

Country Status (1)

Country Link
DE (1) DE4419783A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019099A2 (en) * 1995-08-25 1996-06-27 Lvmh Recherche Use of vitamin c or derivatives or analogues thereof for promoting skin elastin synthesis
FR2738743A1 (en) * 1995-09-19 1997-03-21 Oreal USE OF ASCORBIC ACID AS AN ACTIVE INGREDIENT FOR THE TREATMENT OF SEBORRHEA IN A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION
WO1997026892A1 (en) * 1996-01-26 1997-07-31 Laboratoires Carilene Combinations of peroxide lipids and organosilicon compounds, cosmetic and dermatological compositions containing same, and uses thereof, in particular for treating alopecia
WO2001093824A1 (en) * 2000-06-06 2001-12-13 Basf Aktiengesellschaft Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
EP1172110A2 (en) * 2000-07-07 2002-01-16 Basf Aktiengesellschaft Use of lipoic acid as a bioavailaty enhancer of mineral salts
WO2002076410A2 (en) * 2001-03-23 2002-10-03 Beiersdorf Ag Cosmetic and dermatological preparations comprising a content of a hop extract or hop-malt extract
EP1515715A2 (en) * 2002-06-26 2005-03-23 Nicholas V. Dr. Perricone Hair and nail treatments using alkanolamines
AT412703B (en) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels USE OF SELIGENICAL PREPARATIONS FOR TOPICAL OR BUCCAL USE
WO2007140856A1 (en) * 2006-06-08 2007-12-13 Henkel Ag & Co. Kgaa Oxidative hair treatment with reduced hair damage
WO2008074579A1 (en) * 2006-12-20 2008-06-26 Henkel Ag & Co. Kgaa Hair color change which protects the skin
WO2008110223A2 (en) * 2007-03-15 2008-09-18 Henkel Ag & Co. Kgaa Perming agent comprising capillary filament structures
US20100209375A1 (en) * 2008-12-11 2010-08-19 Maxime Deboni Process for treating keratin fibers with at least one heterocyclic disulfide entity in the presence of at least one reducing agent, optionally heat, and optionally at alkaline ph.
FR2956813A1 (en) * 2010-02-26 2011-09-02 Lea Lab Shampoo, useful for washing and/or hair care and scalp, comprises detersive surfactant component comprising an anionic detergent surfactant, emollient derived from vegetable oil, an active agent and water
WO2012080223A1 (en) 2010-12-15 2012-06-21 Sigea S.R.L. Use of glycosaminoglycan lipoate esters in the trichology field
WO2015090856A1 (en) * 2013-12-18 2015-06-25 Henkel Ag & Co. Kgaa Hair treatment means having a specific conditioning means combination containing lipoic acid ester

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019099A2 (en) * 1995-08-25 1996-06-27 Lvmh Recherche Use of vitamin c or derivatives or analogues thereof for promoting skin elastin synthesis
WO1996019099A3 (en) * 1995-08-25 1997-04-10 Lvmh Rech Use of vitamin c or derivatives or analogues thereof for promoting skin elastin synthesis
GB2308811A (en) * 1995-08-25 1997-07-09 Lvmh Rech Use of vitamin C or derivatives or analogues thereof for promoting skin elastic synthesis
BE1009858A5 (en) * 1995-08-25 1997-10-07 Lvmh Rech Use of vitamin c or derivatives or similar to stimulate the synthesis of skin elastin.
US5801192A (en) * 1995-08-25 1998-09-01 Lvmh Recherche Use of vitamin C or derivatives or analogues thereof promoting skin elastin synthesis
ES2129013A1 (en) * 1995-08-25 1999-05-16 Lvmh Rech Use of vitamin c or derivatives or analogues thereof for promoting skin elastin synthesis
GB2308811B (en) * 1995-08-25 2000-04-05 Lvmh Rech Use of vitamin C or derivatives or analogues thereof for promoting skin elastin synthesis
FR2738743A1 (en) * 1995-09-19 1997-03-21 Oreal USE OF ASCORBIC ACID AS AN ACTIVE INGREDIENT FOR THE TREATMENT OF SEBORRHEA IN A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION
EP0771557A1 (en) * 1995-09-19 1997-05-07 L'oreal Use of ascorbic acid as the actif for the treatment of seborrhea in a cosmetic and/or dermatalogical composition
WO1997026892A1 (en) * 1996-01-26 1997-07-31 Laboratoires Carilene Combinations of peroxide lipids and organosilicon compounds, cosmetic and dermatological compositions containing same, and uses thereof, in particular for treating alopecia
FR2744017A1 (en) * 1996-01-26 1997-08-01 Carilene Lab ASSOCIATIONS OF PEROXIDIC LIPIDS AND ORGANOSILIC COMPOUNDS, COSMETIC AND DERMATOLOGICAL COMPOSITIONS CONTAINING SAME AND THEIR APPLICATIONS IN PARTICULAR FOR THE TREATMENT OF ALOPECIA
WO2001093824A1 (en) * 2000-06-06 2001-12-13 Basf Aktiengesellschaft Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
EP1172110A3 (en) * 2000-07-07 2003-09-17 Basf Aktiengesellschaft Use of lipoic acid as a bioavailaty enhancer of mineral salts
EP1172110A2 (en) * 2000-07-07 2002-01-16 Basf Aktiengesellschaft Use of lipoic acid as a bioavailaty enhancer of mineral salts
US6887894B2 (en) 2000-07-07 2005-05-03 Basf Aktiengesellschaft Use of lipoic acid for improving the bioavailability of mineral salts
WO2002076410A3 (en) * 2001-03-23 2003-09-25 Beiersdorf Ag Cosmetic and dermatological preparations comprising a content of a hop extract or hop-malt extract
WO2002076410A2 (en) * 2001-03-23 2002-10-03 Beiersdorf Ag Cosmetic and dermatological preparations comprising a content of a hop extract or hop-malt extract
AT412703B (en) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels USE OF SELIGENICAL PREPARATIONS FOR TOPICAL OR BUCCAL USE
EP1515715A4 (en) * 2002-06-26 2006-06-14 Perricone Nicholas V Dr Hair and nail treatments using alkanolamines
EP1515715A2 (en) * 2002-06-26 2005-03-23 Nicholas V. Dr. Perricone Hair and nail treatments using alkanolamines
WO2007140856A1 (en) * 2006-06-08 2007-12-13 Henkel Ag & Co. Kgaa Oxidative hair treatment with reduced hair damage
WO2008074579A1 (en) * 2006-12-20 2008-06-26 Henkel Ag & Co. Kgaa Hair color change which protects the skin
WO2008110223A2 (en) * 2007-03-15 2008-09-18 Henkel Ag & Co. Kgaa Perming agent comprising capillary filament structures
WO2008110223A3 (en) * 2007-03-15 2009-11-05 Henkel Ag & Co. Kgaa Perming agent comprising capillary filament structures
US20100209375A1 (en) * 2008-12-11 2010-08-19 Maxime Deboni Process for treating keratin fibers with at least one heterocyclic disulfide entity in the presence of at least one reducing agent, optionally heat, and optionally at alkaline ph.
FR2956813A1 (en) * 2010-02-26 2011-09-02 Lea Lab Shampoo, useful for washing and/or hair care and scalp, comprises detersive surfactant component comprising an anionic detergent surfactant, emollient derived from vegetable oil, an active agent and water
WO2012080223A1 (en) 2010-12-15 2012-06-21 Sigea S.R.L. Use of glycosaminoglycan lipoate esters in the trichology field
WO2015090856A1 (en) * 2013-12-18 2015-06-25 Henkel Ag & Co. Kgaa Hair treatment means having a specific conditioning means combination containing lipoic acid ester

Similar Documents

Publication Publication Date Title
DE4419783A1 (en) Medicated shampoo for hair care and treatment
DE60313597T2 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS WITH PROANTHOCYANIDINES, GLYCYRRHETINIC ACID AND TELEMINE TESTS FOR THE TREATMENT OF DERMATITIS
DE69730604T2 (en) OXADIC ACIDS AND RELATED COMPOUNDS FOR THE TREATMENT OF SKIN DISORDER
EP0545147B1 (en) Use of super oxid dismutase for preventing or delaying human hair greying
CH684739A5 (en) Skin lightening composition
DE112007001469T5 (en) Collagen Synthesis Promoter Containing Zinc as an Active Ingredient
DE60117606T2 (en) ORAL COMPOSITIONS FOR THE TREATMENT OF HEADACHE DISORDERS
EP0209724B1 (en) Preparation effective against acne and the use of an active extract of couch grass
DE2906213A1 (en) COSMETIC AND THERAPEUTIC CLEANER
CN107496317A (en) A kind of restoration care shampoo of the active component containing American cockroach
CA2485380A1 (en) A pharmaceutical composition for the treatment of seborrhea containing ovalicin
Arya et al. Nanomaterials in the cosmetics industry: A greener approach
JP2000336062A (en) Formulated substance preserved with sorbate, its production and its use
JPS61129106A (en) Dermaphilic cosmetic composition
JPH11240827A (en) Preparation composition for external use containing gamma-polyglutamic acid and vegetable extract in combination
DE60106014T2 (en) USE OF N, N'-DIBENZYLETHYLENEDIAMINO-SODIUM DERIVATIVES FOR PROTECTION AGAINST POLLUTION
DE3784821T2 (en) COMPOSITION FOR USE ON HAIR.
Pingale et al. A review on alopecia and its remedies
DE4441873A1 (en) Means for permanent hair deformation
JPS62142108A (en) Hair tonic composition
FR2609390A1 (en) CAPILLARY COMPOSITION
JP2004149424A (en) Cosmetic and method for improving humectant function of cosmetic
DE3840832A1 (en) Product for external use
FR2656523A1 (en) Compositions for cosmetic and/or dermatological use, comprising metal pidolates
DE19757921A1 (en) New hair treatment composition to stimulate hair growth

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8130 Withdrawal